CSIR-NIIST introduces new tech for biomedical waste safety
WATER & WASTE

CSIR-NIIST introduces new tech for biomedical waste safety

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country.

This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26.

As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing.

Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste.

Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, "This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration."

Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source.

However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board.

"CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept," he had added.

Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

The CSIR-National Institute for Interdisciplinary Science and Technology (CSIR-NIIST) had introduced a pioneering technology aimed at the safe, sustainable, and cost-effective management of biomedical waste, representing a significant milestone as the first of its kind in the country. This groundbreaking technology had been unveiled during the Biomedical Waste Management Conclave, a one-day event held at the CSIR-NIIST campus in the city on March 26. As reported by UNI, Dr M Srinivas, Director of AIIMS New Delhi, had inaugurated the event, which had been presided over by Dr N Kalaiselvi, Secretary of DSIR and Director General of CSIR, via videoconferencing. Dr Srinivas had stressed the importance of innovative technologies in the biomedical sector and had reiterated AIIMS' commitment to collaborating with academic and research institutions, particularly CSIR. He had praised CSIR-NIIST Director Dr C Anandharamakrishnan and his team for their innovative solution for the disposal of pathogenic biomedical waste. Dr Kalaiselvi had remarked that the biomedical waste treatment technology developed by CSIR-NIIST would effectively tackle one of the major challenges of modern times. She had noted, This technology will significantly impact the global biomedical arena by addressing the limitations of conventional technologies, including energy-intensive incineration. Dr Anandharamakrishnan had explained that with the technology, one kilogram of medical waste could be converted into soil additives in three minutes, suitable for agricultural purposes. As per the UNI news agency, he had mentioned that this safe and cost-effective technology would facilitate hospitals in disposing of medical waste easily at its source. However, the implementation of this technology in hospitals nationwide necessitated approval from the Central Pollution Control Board. CSIR-NIIST is actively exploring various waste management strategies, including biomedical waste. The technology we developed for converting pathogenic biomedical waste into value-added soil additives serves as a perfect example of the 'Waste to Wealth' concept, he had added. Following the development of this groundbreaking technology, CSIR-NIIST had transferred it to Bio Vastum Solutions, a firm based in Angamaly.

Related Stories

Gold Stories

Next Story
Resources

Schindler named among Forbes’ World’s Best Employers 2026

Schindler has been named among Forbes’ World’s Best Employers 2026, a global ranking recognising companies for their workplace environments.Compiled by Forbes in partnership with Statista, the ranking is based on independent employee feedback, including whether employees would recommend their organisation to friends and family.The company said the recognition reflected its focus on creating a workplace where employees can develop their expertise and build careers. ..

Next Story
Infrastructure Urban

India needs an export-execution mindset: Vishesh Jain

Interview with Vishesh Jain, Founder & CEO, EximpleWhat gaps in India’s global trade ecosystem led you to build Eximple, and what problem did you see businesses struggling with most?Eximple came out of a problem that all three founders had seen from different choke points in the trade ecosystem. India has millions of MSMEs and manufacturers, and many of them can make products that are genuinely competitive on quality. Yet only a small fraction is able to build meaningful international businesses. In our experience, the gap is usually not manufacturing capability; it is the ability to exe..

Next Story
Building Material

Nuvoco reports 13.5% revenue growth in Q2 FY27

Nuvoco Vistas Corp. Ltd. reported consolidated revenue of Rs 27.9 billion for Q2 FY27, up 13.5% year on year. Cement sales volume rose 9% to 4.7 million tonnes (MMT), while EBITDA increased 11% to Rs 4.11 billion.The company said it began its cement operations in 2014 with a 2.3 MMT per annum (MMTPA) operation at Nimbol. It now aims to reach 35 MMTPA of cement capacity by FY28, nearly 15 times its initial capacity. Its portfolio spans cement, ready-mix concrete and modern building materials.On sustainability and cost efficiency, Nuvoco partnered with CleanMax for a 46.4 MW wind-solar hybrid re..

Advertisement

Subscribe to Our Newsletter

Get daily newsletters around different themes from Construction world.

STAY CONNECTED

Advertisement

SPECIAL OFFER
QR Code